Quia C. Claybourne

Quia C. Claybourne

Auto-generated profile, based on publicly available information

Quia C. Claybourne

Comparative Medicine Section, National Institute on Aging NIH Baltimore Maryland USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2022 in Cell Reports
Verified
Journal Article
Open access
SRShah Md Toufiqur Rahman
Shah Md Toufiqur Rahman
MAMohammad Aqdas
Mohammad Aqdas
EMErik W. Martin
Erik W. Martin
FAFrancesco Tomassoni Ardori
Francesco Tomassoni Ardori
PSPreeyaporn Songkiatisak
Preeyaporn Songkiatisak
Myong-Hee SungMyong-Hee Sung
Myong-Hee Sung
In vitro studies suggest that mapping the spatiotemporal complexity of nuclear factor κB (NF-κB) signaling is essential to understanding its function. The lack of tools to directly monitor NF-κB proteins in vivo has hindered such efforts. Here, we introduce reporter mice with the endogenous RelA (p65) or c-Rel labeled with distinct fluorescent proteins and a double knockin with both subunits labeled. Overcoming hurdles in simultaneous live-cell imaging of RelA and c-Rel, we show that quantitative features of signaling reflect the identity of activating ligands, differ between primary and immortalized cells, and shift toward c-Rel in microglia from aged brains. RelA:c-Rel heterodimer is unexpectedly depleted in the nuclei of stimulated cells. Trajectories of subunit co-expression in immune lineages reveal a reduction at key cell maturation stages. These results demonstrate the power of these reporters in gaining deeper insights into NF-κB biology, with the spectral complementarity of the labeled NF-κB proteins enabling diverse applications.

4 July 2023 in Glia
Verified
Journal Article
Open access
EGElliot Glotfelty
Elliot Glotfelty
SHShih‐Chang Hsueh
Shih‐Chang Hsueh
QCQuia Claybourne
Quia Claybourne
ABAlicia Bedolla
Alicia Bedolla
KKKatherine Kopp
Katherine Kopp
NGNigel H Greig
Nigel H Greig
Nogo‐A, B, and C are well described members of the reticulon family of proteins, most well known for their negative regulatory effects on central nervous system (CNS) neurite outgrowth and repair following injury. Recent research indicates a relationship between Nogo‐proteins and inflammation. Microglia, the brain's immune cells and inflammation‐competent compartment, express Nogo protein, although specific roles of the Nogo in these cells is understudied. To examine inflammation‐related effects of Nogo, we generated a microglial‐specific inducible Nogo KO (MinoKO) mouse and challenged the mouse with a controlled cortical impact (CCI) traumatic brain injury (TBI). Histological analysis shows no difference in brain lesion sizes between MinoKO‐CCI and Control‐CCI mice, although MinoKO‐CCI mice do not exhibit the levels of ipsilateral lateral ventricle enlargement as injury matched controls. Microglial Nogo‐KO results in decreased lateral ventricle enlargement, microglial and astrocyte immunoreactivity, and increased microglial morphological complexity compared to injury matched controls, suggesting decreased tissue inflammation. Behaviorally, healthy MinoKO mice do not differ from control mice, but automated tracking of movement around the home cage and stereotypic behavior, such as grooming and eating (termed cage “activation”), following CCI is significantly elevated. Asymmetrical motor function, a deficit typical of unilaterally brain lesioned rodents, was not detected in CCI injured MinoKO mice, while the phenomenon was present in CCI injured controls 1‐week post‐injury. Overall, our studies show microglial Nogo as a negative regulator of recovery following brain injury. To date, this is the first evaluation of the roles microglial specific Nogo in a rodent injury model.